bisbenzimidazole has been researched along with Brain Neoplasms in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, A | 1 |
| Marecos, E | 1 |
| Bogdanov, A | 1 |
| Weissleder, R | 1 |
1 other study available for bisbenzimidazole and Brain Neoplasms
| Article | Year |
|---|---|
Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model.
Topics: Animals; Biomarkers, Tumor; Bisbenzimidazole; Brain Neoplasms; Cell Division; Contrast Media; Dextra | 2000 |